Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Abstract 1619: Discovering a new physiological substrate of Aurora-A kinase

View through CrossRef
Abstract Aurora-A is a serine/threonine kinase that has oncogenic properties in vivo. The expression and kinase activity of Aurora-A are up-regulated in many cancers including prostate cancer, which is the most frequently diagnosed malignancy in men and second leading cause of cancer death in the United States. Aurora-A is one of the key regulators of mitosis that localizes to the centrosome from G2 phase through mitotic exit, where it regulates mitotic spindle formation and centrosome separation. Although Aurora-A is known to be an oncogene, few Aurora-A substrates have been identified. It is essential to elucidate Aurora-A substrates to develop biomarkers for Aurora-A inhibitors, and to identify new targets downstream of Aurora-A for cancer therapy. To identify new Aurora-A substrates, an Aurora-A Reverse In-gel Kinase Assay was developed. The basis of this method is co-polymerization of a denatured protein kinase throughout a polyacrylamide gel followed by protein refolding. Subsequently, an in-gel kinase reaction in the presence of γ-32P-ATP allows phosphorylation of potential kinase substrates that can be located by autoradiography. Phosphorylated proteins can be extracted from the gel and identified by liquid chromatography mass spectrometry. Using this method, we were able to identify Nuclear Mitotic Apparatus (NuMA) as an Aurora-A kinase substrate. Preliminary in vitro kinase experiments verify phosphorylation of recombinant NuMA C-terminus by Aurora-A. The identification of Aurora-A phosphorylation site/s will permit a better understanding of Aurora-A function in normal and cancer cells. The location of Aurora-A phosphorylation of NuMA and consequences of their mutation will be discussed. Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 102nd Annual Meeting of the American Association for Cancer Research; 2011 Apr 2-6; Orlando, FL. Philadelphia (PA): AACR; Cancer Res 2011;71(8 Suppl):Abstract nr 1619. doi:10.1158/1538-7445.AM2011-1619
Title: Abstract 1619: Discovering a new physiological substrate of Aurora-A kinase
Description:
Abstract Aurora-A is a serine/threonine kinase that has oncogenic properties in vivo.
The expression and kinase activity of Aurora-A are up-regulated in many cancers including prostate cancer, which is the most frequently diagnosed malignancy in men and second leading cause of cancer death in the United States.
Aurora-A is one of the key regulators of mitosis that localizes to the centrosome from G2 phase through mitotic exit, where it regulates mitotic spindle formation and centrosome separation.
Although Aurora-A is known to be an oncogene, few Aurora-A substrates have been identified.
It is essential to elucidate Aurora-A substrates to develop biomarkers for Aurora-A inhibitors, and to identify new targets downstream of Aurora-A for cancer therapy.
To identify new Aurora-A substrates, an Aurora-A Reverse In-gel Kinase Assay was developed.
The basis of this method is co-polymerization of a denatured protein kinase throughout a polyacrylamide gel followed by protein refolding.
Subsequently, an in-gel kinase reaction in the presence of γ-32P-ATP allows phosphorylation of potential kinase substrates that can be located by autoradiography.
Phosphorylated proteins can be extracted from the gel and identified by liquid chromatography mass spectrometry.
Using this method, we were able to identify Nuclear Mitotic Apparatus (NuMA) as an Aurora-A kinase substrate.
Preliminary in vitro kinase experiments verify phosphorylation of recombinant NuMA C-terminus by Aurora-A.
The identification of Aurora-A phosphorylation site/s will permit a better understanding of Aurora-A function in normal and cancer cells.
The location of Aurora-A phosphorylation of NuMA and consequences of their mutation will be discussed.
Citation Format: {Authors}.
{Abstract title} [abstract].
In: Proceedings of the 102nd Annual Meeting of the American Association for Cancer Research; 2011 Apr 2-6; Orlando, FL.
Philadelphia (PA): AACR; Cancer Res 2011;71(8 Suppl):Abstract nr 1619.
doi:10.
1158/1538-7445.
AM2011-1619.

Related Results

Aurora-A Kinase: A Novel Target for the Immunotherapy Against Human Leukemias.
Aurora-A Kinase: A Novel Target for the Immunotherapy Against Human Leukemias.
Abstract Aurora-A kinase (Aurora-A) is one of the serine/threonine kinase families, which is located on the long arm of chromosome 20q13, is mainly expressed in G2/M...
Phosphorylation of NuMA by Aurora‐A kinase in PC‐3 prostate cancer cells affects proliferation, survival, and interphase NuMA localization
Phosphorylation of NuMA by Aurora‐A kinase in PC‐3 prostate cancer cells affects proliferation, survival, and interphase NuMA localization
AbstractAurora‐A is a serine/threonine kinase that has oncogenic properties in vivo. The expression and kinase activity of Aurora‐A are up‐regulated in multiple malignancies. Auror...
KNL1 facilitates phosphorylation of outer kinetochore proteins by promoting Aurora B kinase activity
KNL1 facilitates phosphorylation of outer kinetochore proteins by promoting Aurora B kinase activity
Aurora B kinase phosphorylates kinetochore proteins during early mitosis, increasing kinetochore–microtubule (MT) turnover and preventing premature stabilization of kinetochore–MT ...
Evaluation of Aurora Activity Obtained from Abisko and Kiruna Ground Based Observation
Evaluation of Aurora Activity Obtained from Abisko and Kiruna Ground Based Observation
<p>Available space weather forecasts mainly use data from the Sun and upstream interplanetary monitoring, to provide the early warning. Although the accuracy is impro...
Protein kinase activities in rat pancreatic islets of Langerhans
Protein kinase activities in rat pancreatic islets of Langerhans
1. Protein kinase activities in homogenates of rat islets of Langerhans were studied. 2. On incubation of homogenates with [gamma-32P]ATP, incorporation of 32P into protein occurre...
Abstract 137: Increased activity of protein kinase A is sufficient to cause fibrolamellar carcinoma
Abstract 137: Increased activity of protein kinase A is sufficient to cause fibrolamellar carcinoma
Abstract Tumor cells of almost all patients with fibrolamellar carcinoma (FLC) have a somatic mutation, a ~400 kB deletion on one copy of chromosome 19 that results ...

Back to Top